Unique ID issued by UMIN | UMIN000025998 |
---|---|
Receipt number | R000029887 |
Scientific Title | Investigation the effect of imprpving on postprandial blood glucose with type 2 diabetic patients by the combination of bran ingestion and alpha glucosidase inhibitor |
Date of disclosure of the study information | 2017/02/04 |
Last modified on | 2018/07/16 21:07:39 |
Investigation the effect of imprpving on postprandial blood glucose with type 2 diabetic patients by the combination of bran ingestion and alpha glucosidase inhibitor
the effect of improving on postprandial blood glucose by the combination of bran ingestion and alpha glucosidase inhibitor
Investigation the effect of imprpving on postprandial blood glucose with type 2 diabetic patients by the combination of bran ingestion and alpha glucosidase inhibitor
the effect of improving on postprandial blood glucose by the combination of bran ingestion and alpha glucosidase inhibitor
Japan |
type 2 diabetes
Endocrinology and Metabolism | Hematology and clinical oncology |
Others
NO
Confirm the ingestion of brown rice bran alone before meals, ingestion of bran and pre-meal ingestion of alpha glucosidase inhibitor in combination with each other, and changes in postprandial blood glucose of each when not taking anything in advance
Efficacy
1 Mean blood glucose of 24 hours
2 MAGE (average value of differences in blood glucose level when blood glucose fluctuation exceeding average + 1SD)
3 total area of blood glucose fluctuation in 24 hours
4 Percentage of time zone of hyperglycemia (> 140 mg / dL)
5 Percentage of time zone of hypoglycemia (<70 mg / dL)
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
No treatment
3
Treatment
Food |
Ingestion of unpolished rice bran before meals
Combined administration of brown rice bran and pre-meal alpha glucosidase inhibitor
No meals before administration
20 | years-old | <= |
74 | years-old | >= |
Male and Female
1. Patients whose age is over 20 years old but less than 75 years old when acquiring consent
2. After receiving sufficient explanation for the participation of this study, patients who obtained document consent by the patient's free will with sufficient understanding
3. Patient in hospital
4. Patients whose blood glucose level is not more than 140 mg / dL on an empty stomach and below 200 mg / dL for 2 hours after a meal
1. Type 1 diabetic patients
2. Patients who have used alpha GI and GLP 1 analog preparations so far
3. Patients using alpha glucosidase inhibitor and GLP-1 analog preparations
4. Women who may be pregnant or may become pregnant
5. Women who are breastfeeding
6. Women in menstruation during the study period
7. Patients determined by the attending physician to be unsuitable for this study
30
1st name | |
Middle name | |
Last name | Yasushi Tanaka |
St Marianna University School of Medicine
Metabolism and Endocrinology
2-16-1, Sugao, Miyamae-ku, Kawasaki-shi, Kanagawa
044-977-8111
y2tanaka@marianna-u.ac.jp
1st name | |
Middle name | |
Last name | Taiga Nakayama |
St. Marianna University School of Medicine
Metabolism and Endocrinology
2-16-1, Sugao, Miyamae-ku, Kawasaki-shi, Kanagawa
044-977-8111
t2nakayama@marianna-u.ac.jp
St Marianna University school of medicine
none
Other
NO
2017 | Year | 02 | Month | 04 | Day |
Unpublished
Terminated
2014 | Year | 03 | Month | 30 | Day |
2014 | Year | 03 | Month | 30 | Day |
2017 | Year | 02 | Month | 04 | Day |
2018 | Year | 07 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029887